The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in Myeloma
Sagar Lonial, MD, FACP, Talks Multiple Myeloma Highlights from the Summer ConferencesПодробнее
ASH Impact Series: Sagar Lonial, MD - Examining Multiple Myeloma Drug Combination TreatmentsПодробнее
The HemOnc Pulse Live at ASH: John DiPersio, MD, PhD, on Challenges, Role of HSCT in AMLПодробнее
The HemOnc Pulse Live at ASH: Jeffrey Lancet, MD, on Targeted Therapies for AMLПодробнее
The HemOnc Pulse Live at ASH: Robert Orlowski, MD, PhD, on Bispecifics, MRD in MyelomaПодробнее
The HemOnc Pulse Live at ASH: Thomas Martin, MD, on Frontline Advances, Novel Agents in MyelomaПодробнее
Sagar Lonial, MD, FACP, on Multiple Myeloma Awareness MonthПодробнее
ASH Impact Series: Sagar Lonial, MD - Treating Newly Diagnosed Multiple MyelomaПодробнее
The HemOnc Pulse Live at ASH: Tycel Phillips, MD, on the TRIANGLE Study, Frontline Therapy in MCLПодробнее
The HemOnc Pulse Live at ASH: Srdan Verstovsek, MD, on MPN Treatment Combinations, TimingПодробнее
DARA + pom-dex for R/R multiple myelomaПодробнее
Recent updates on CELMoDs in multiple myelomaПодробнее
Dr. Lonial on Treatment of Patients With Late Relapse MyelomaПодробнее
Topics in multiple myeloma discussed at ASCO 2016Подробнее
State of the art clinical trials with the UK Myeloma ForumПодробнее
Final analysis of the DREAMM-2 trial: belantamab mafodotin for R/R multiple myelomaПодробнее
Prof. Sagar Lonial | ASH 2017 | Highlights of ASH in RRMMПодробнее
Dr Sagar Lonial discusses new data from ASCO and EHA 2019 in the Transplant & Induction settingПодробнее
Dr. Lonial Discusses Novel Agents in Multiple MyelomaПодробнее
